|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/68 | (2017.01) |
| A61K 45/06 | (2006.01) | ||
| A61K 31/4745 | (2006.01) | ||
| A61K 31/704 | (2006.01) | ||
| A61K 31/166 | (2006.01) | ||
| A61K 35/00 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/02 | (2006.01) | ||
| A61P 35/04 | (2006.01) |
| (11) | Number of the document | 3204018 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15849252.0 |
| Date of filing the European patent application | 2015-10-05 | |
| (97) | Date of publication of the European application | 2017-08-16 |
| (45) | Date of publication and mention of the grant of the patent | 2021-08-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/054011 |
| Date | 2015-10-05 |
| (87) | Number | WO 2016/057398 |
| Date | 2016-04-14 |
| (30) | Number | Date | Country code |
| 201462060858 P | 2014-10-07 | US |
| (72) |
GOLDENBERG, David M. , US
|
| (73) |
Immunomedics, Inc. ,
300 American Road, Morris Plains, NJ 07950,
US
|
| (54) | NEOADJUVANT USE OF ANTIBODY-DRUG CONJUGATES |
| NEOADJUVANT USE OF ANTIBODY-DRUG CONJUGATES |